CONDITION
Pericardial Effusion
Pericardial effusion involves accumulation of fluid within the sac surrounding the heart, which can compress the heart and impair its function, presenting with signs of cardiovascular compromise.
Why this matters now
Pericardial effusion typically affects middle-aged to older dogs, with large and giant breeds showing increased susceptibility. The condition can develop gradually or accumulate rapidly, with sudden presentations sometimes occurring as the first indication of underlying disease.
As fluid accumulates in the pericardial sac, pressure on the heart increases. Initially, the heart may compensate, but as volume grows, the right side of the heart becomes compressed, impairing its ability to fill with blood. This leads to backing up of blood in the venous system and reduced forward blood flow, causing the clinical signs of right-sided heart failure.
Signals & patterns
Early signals
Exercise intolerance
Reduced stamina and reluctance to engage in normal activity may reflect compromised heart function.
Mild lethargy
General decrease in energy levels as cardiovascular efficiency declines.
Reduced appetite
Dogs may eat less as blood flow to digestive organs decreases.
Occasional coughing
May occur though less prominent than with other heart conditions.
Later signals
Abdominal distension
Fluid accumulates in the abdomen (ascites) as blood backs up in the venous system.
Laboured breathing
Respiratory effort increases as body demands more oxygen than compromised circulation can deliver.
Pale gums
Reduced blood flow causes the mucous membranes to appear pale rather than healthy pink.
Collapse episodes
Sudden weakness or fainting may occur, particularly with exertion or excitement.
Click to read about the biological mechanisms
How this is usually investigated
Diagnosis combines clinical findings suggesting right-sided heart failure with imaging to confirm fluid presence and identify potential underlying causes.
Echocardiography
Chest radiographs
Electrocardiogram (ECG)
Pericardiocentesis with fluid analysis
Abdominal ultrasound
Cardiac troponin levels
Options & trade-offs
Management depends on the underlying cause and ranges from emergency fluid drainage to long-term surgical options, with prognosis varying significantly based on aetiology.
Pericardiocentesis
Needle drainage of fluid from the pericardial sac, often guided by ultrasound
Trade-offs: Immediately relieves tamponade; can be repeated if fluid recurs; carries some procedural risk.
Pericardiectomy
Surgical removal of part of the pericardium to prevent future fluid accumulation
Trade-offs: Can provide lasting solution for idiopathic cases; major surgery; prognosis depends on cause.
Treatment of underlying cancer
Chemotherapy for responsive tumour types when cancer is the cause
Trade-offs: May extend quality time; effectiveness varies with tumour type; hemangiosarcoma carries guarded prognosis.
Anti-inflammatory therapy
Medications for idiopathic or inflammatory pericarditis
Trade-offs: May reduce fluid production; generally well tolerated; not effective for neoplastic causes.
Supportive care
Diuretics, rest restriction, and monitoring for recurrence
Trade-offs: Manages secondary effects; buying time while determining next steps.
Common misconceptions
"Pericardial effusion always means cancer"
While cardiac tumours are a common cause, idiopathic pericarditis accounts for a significant proportion of cases and carries a much better prognosis.
"Once drained, the problem is solved"
Fluid often reaccumulates, particularly with ongoing underlying disease; monitoring and potentially further intervention may be needed.
"Dogs with pericardial effusion are always obviously unwell"
Gradual accumulation allows adaptation; some dogs present with subtle signs before acute decompensation.
Owners of large-breed dogs showing signs of exercise intolerance, abdominal swelling, or collapse episodes may find value in cardiovascular assessment. Understanding that both the severity and the underlying cause influence prognosis can help guide discussions about investigation and treatment options.
Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS